BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17000773)

  • 1. Activation of alpha-tropomyosin exon 2 is regulated by the SR protein 9G8 and heterogeneous nuclear ribonucleoproteins H and F.
    Crawford JB; Patton JG
    Mol Cell Biol; 2006 Dec; 26(23):8791-802. PubMed ID: 17000773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
    Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
    J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
    Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
    EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon.
    Gooding C; Roberts GC; Smith CW
    RNA; 1998 Jan; 4(1):85-100. PubMed ID: 9436911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat beta-tropomyosin gene.
    Chen CD; Kobayashi R; Helfman DM
    Genes Dev; 1999 Mar; 13(5):593-606. PubMed ID: 10072387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a component of an intronic splicing enhancer complex that activates the splicing of the alternative exon 6A from chicken beta-tropomyosin pre-mRNA.
    Expert-Bezançon A; Le Caer JP; Marie J
    J Biol Chem; 2002 May; 277(19):16614-23. PubMed ID: 11867641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and cloning of the human splicing factor 9G8: a novel 35 kDa factor of the serine/arginine protein family.
    Cavaloc Y; Popielarz M; Fuchs JP; Gattoni R; Stévenin J
    EMBO J; 1994 Jun; 13(11):2639-49. PubMed ID: 8013463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exonic splicing enhancers contribute to the use of both 3' and 5' splice site usage of rat beta-tropomyosin pre-mRNA.
    Selvakumar M; Helfman DM
    RNA; 1999 Mar; 5(3):378-94. PubMed ID: 10094307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences.
    Schaal TD; Maniatis T
    Mol Cell Biol; 1999 Mar; 19(3):1705-19. PubMed ID: 10022858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancer elements activate the weak 3' splice site of alpha-tropomyosin exon 2.
    Dye BT; Buvoli M; Mayer SA; Lin CH; Patton JG
    RNA; 1998 Dec; 4(12):1523-36. PubMed ID: 9848651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.
    Cavaloc Y; Bourgeois CF; Kister L; Stévenin J
    RNA; 1999 Mar; 5(3):468-83. PubMed ID: 10094314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of PTB binding sites causes misregulation of alternative 3' splice site selection in vivo.
    Pérez I; Lin CH; McAfee JG; Patton JG
    RNA; 1997 Jul; 3(7):764-78. PubMed ID: 9214659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
    Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
    J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H'/F/2H9 family.
    Caputi M; Zahler AM
    J Biol Chem; 2001 Nov; 276(47):43850-9. PubMed ID: 11571276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human RBMY regulates germline-specific splicing events by modulating the function of the serine/arginine-rich proteins 9G8 and Tra2-{beta}.
    Dreumont N; Bourgeois CF; Lejeune F; Liu Y; Ehrmann IE; Elliott DJ; Stévenin J
    J Cell Sci; 2010 Jan; 123(Pt 1):40-50. PubMed ID: 20016065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F.
    Coles JL; Hallegger M; Smith CW
    RNA; 2009 Jan; 15(1):33-43. PubMed ID: 19037011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypyrimidine tract binding protein functions as a repressor to regulate alternative splicing of alpha-actinin mutally exclusive exons.
    Southby J; Gooding C; Smith CW
    Mol Cell Biol; 1999 Apr; 19(4):2699-711. PubMed ID: 10082536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic factors control the unproductive splicing of SC35 terminal intron.
    Dreumont N; Hardy S; Behm-Ansmant I; Kister L; Branlant C; Stévenin J; Bourgeois CF
    Nucleic Acids Res; 2010 Mar; 38(4):1353-66. PubMed ID: 19965769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.